Cargando…
Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial
Autores principales: | Arnardottir, Hildur, Pawelzik, Sven‐Christian, Sarajlic, Philip, Quaranta, Alessandro, Kolmert, Johan, Religa, Dorota, Wheelock, Craig E., Bäck, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484265/ https://www.ncbi.nlm.nih.gov/pubmed/36121173 http://dx.doi.org/10.1002/ctm2.895 |
Ejemplares similares
-
Decreased oxidative stress and altered urinary oxylipidome by intravenous omega-3 fatty acid emulsion in a randomized controlled trial of older subjects hospitalized for COVID-19
por: Pawelzik, Sven-Christian, et al.
Publicado: (2023) -
Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial
por: Arnardottir, Hildur, et al.
Publicado: (2021) -
The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification
por: Carracedo, Miguel, et al.
Publicado: (2019) -
Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis
por: Artiach, Gonzalo, et al.
Publicado: (2020) -
Reply to Thomson: Exposure to Active and Passive Tobacco Smoke on Urinary Eicosanoid Metabolites in Type 2 Asthma
por: Kolmert, Johan, et al.
Publicado: (2021)